Plaque, Amyloid
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
To study the effect of amyloid deposits on cell cycle related events in vivo, the expression of cell cycle markers was examined by immunohistochemistry in amyloid precursor protein (APP) transgenic mice (APP23 mice, Swedish double mutation).
|
12923647 |
2003 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
It is also possible that the human APP gene responsible for HSD-10 deposition in APs of these Tg2576 mice brains is different from that of AD brains.
|
12393239 |
2002 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
Transgenic designs emphasizing amyloid precursor protein produced mice that develop amyloid plaques, but neurodegeneration and neurofibrillary tangles failed to form.
|
11917160 |
2002 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
The central component of senile amyloid plaques in Alzheimer's disease (AD) is the beta-amyloid peptide (Abeta), derived from proteolytic processing of the amyloid precursor protein (APP).
|
11421596 |
2001 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
Here, we describe significant CAA in addition to amyloid plaques, in aging APP/Ld transgenic mice overexpressing the London mutant of human amyloid precursor protein (APP) exclusively in neurons.
|
11021833 |
2000 |
Plaque, Amyloid
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The transmembrane domain and a portion of the C-terminus (A beta) of the amyloid precursor protein, are known to form the nucleus of the amyloid plaque.
|
10192224 |
1999 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
The amyloid precursor protein (APP) has been associated with Alzheimer's disease (AD) because APP is processed into the beta-peptide that accumulates in amyloid plaques, and APP gene mutations can cause early onset AD.
|
10037734 |
1999 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
The increased expression and/or abnormal processing of the amyloid precursor protein (APP) is associated with the formation of amyloid plaques and cerebrovascular amyloid deposits, which are one of the major morphological hallmarks of Alzheimer's disease (AD).
|
9775403 |
1998 |
Plaque, Amyloid
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Models of AD include: aged monkeys that show both cognitive/memory deficits and cellular abnormalities (amyloid deposition/cytoskeletal abnormalities of neurons) in cortex and hippocampus; and Tg mice that express mutant human FAD-linked genes (i.e., APP and PS1) and show increased levels of A.42, amyloid deposits, dystrophic neurites, and local responses of astrocytes and microglia.
|
9683997 |
1997 |
Plaque, Amyloid
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In this report, we demonstrate that transgenic animals that coexpress a FAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish FAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone.
|
9354339 |
1997 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
The main component of senile plaque amyloid is a 39-to 42-amino-acid segment referred to as beta-amyloid, which is derived from amyloid precursor protein (APP).
|
8809275 |
1996 |
Plaque, Amyloid
|
0.400 |
Biomarker
|
disease |
BEFREE |
The 4-kDa beta-amyloid peptide (Abeta), a principal component of parenchymal amyloid deposits in Alzheimer's disease, is derived from amyloid precursor proteins (APP).
|
8621605 |
1996 |